Biofunctions of three new B7 family members (IRM7P.486)

Authors:

Abstract
Recently, three new B7 family members, B7-H5 (VISTA, Gi24, or Dies1), B7-H6, and B7-H7 (HHLA2) were identified. However, the functions of the three new B7 family members remain uncertain. We expressed the human B7-H5, B7-H6, and B7-H7 extracellular domain human IgG1 Fc Chimera in mammalian cell line and investigated the functions of the purified recombinant B7-H5/Fc, B7-H6/Fc, and B7-H7/Fc in vitro. To determine the functions of B7-H5 and B7-H7, human T cells were treated with plate-bound anti-CD3 and either B7-H5/Fc, B7-H7/Fc or control IgG1 Fc. The cytokine levels of supernatant were measured using the Proteome Profiler Human Cytokine Array and Quantikine ELISA kit. B7-H5 significantly reduced production of seven cytokines from T cells including IFN-γ, IL-2, IL-4, IL-8, IL-13, IL-16, and TNF-α. B7-H7 markedly decreased four cytokines including IFN-γ, IL-2, IL-8, and TNF-α. To investigate the bioactivity of B7-H6, NK92 cells were treated with plate-bound B7-H6/Fc or control IgG1 Fc. B7-H6/Fc induced IFN-γ production in NK cells in a dose dependent manner. Furthermore, B7-H6/Fc showed binding to recombinant human NKp30/Fc. Taken together, our data suggest that B7-H5 and B7-H7 are co-inhibitory molecules for T cell activation. Our data also indicate that B7-H6, a major NKp30 ligand, triggers NKp30-dependent NK cell activation.